Osteoporosis Treatment Market to Hit Market Size of US$ 16.6 Billion by 2030, Says a Market Report by RationalStat
November 09, 2023 01:21 ET
|
Rationalstat LLC
Wilmington Delaware, Nov. 09, 2023 (GLOBE NEWSWIRE) -- Global Osteoporosis Treatment Market is valued at US$ 12.0 billion in 2023 and is expected to grow at a significant CAGR of over 4.8% over the...
Vitamin K2 Market Worth $1.16 Billion, Globally, by 2030 - Exclusive Report by The Insight Partners
October 16, 2023 07:52 ET
|
The Insight Partners
Pune, India, Oct. 16, 2023 (GLOBE NEWSWIRE) -- Vitamin K2, also known as menaquinone, is a part of vitamin K family. It plays an important role in keeping bones and heart healthy. MK-4 and MK-7 are...
Rani Therapeutics to Present Abstract on RT-102 at the 2023 Annual Meeting of the American Society for Bone and Mineral Research
October 12, 2023 16:05 ET
|
Rani Therapeutics, LLC
SAN JOSE, Calif., Oct. 12, 2023 (GLOBE NEWSWIRE) -- Rani Therapeutics Holdings, Inc. (“Rani Therapeutics” or “Rani”) (Nasdaq: RANI), a clinical-stage biotherapeutics company focused on the oral...
Entera Bio Announces Collaboration with OPKO Biologics to Develop Oral Peptide Tablet Formulations for Obesity and Intestinal Malabsorption Syndromes
September 12, 2023 08:30 ET
|
Entera Bio Ltd.
JERUSALEM, Sept. 12, 2023 (GLOBE NEWSWIRE) -- Entera Bio Ltd. (NASDAQ: ENTX, “Entera”) and OPKO Biologics, Inc., a subsidiary of OPKO Health, Inc. (NASDAQ: OPK, “OPKO”) have entered into a Research...
Vitamin D Testing Market Size & Share to Hit USD 1.06 billion by 2031, Expanding at a CAGR of 5.8% - Exclusive Report by Transparency Market Research
September 11, 2023 10:26 ET
|
Transparency Market Research
Wilmington, Delaware, United States, Sept. 11, 2023 (GLOBE NEWSWIRE) -- Transparency Market Research Inc. - The global vitamin D testing market is projected to flourish at a CAGR of 5.8% from 2022...
Entera Bio to Participate in Upcoming Investor Conferences
September 05, 2023 08:00 ET
|
Entera Bio Ltd.
JERUSALEM, Sept. 05, 2023 (GLOBE NEWSWIRE) -- Entera Bio Ltd. (NASDAQ: ENTX), (“Entera” or the “Company”) a leader in the development of orally delivered peptides and therapeutic proteins, today...
Rani Therapeutics Reports Second Quarter 2023 Financial Results; Provides Corporate Update
August 11, 2023 16:05 ET
|
Rani Therapeutics, LLC
- Expansion of partnership with Celltrion for development of RT-105 to complement existing partnership for RT-111 - Appointment of Kate McKinley as Chief Business Officer - Presentation of three...
Entera Bio Announces Q2 2023 Financial Results and Corporate Updates
August 11, 2023 16:05 ET
|
Entera Bio Ltd.
JERUSALEM, Aug. 11, 2023 (GLOBE NEWSWIRE) -- Entera Bio Ltd. (NASDAQ: ENTX), (“Entera” or the “Company”) a leader in the development of orally delivered peptides and therapeutic proteins, today...
Rani Therapeutics to Participate in August Investor Conferences
August 04, 2023 16:05 ET
|
Rani Therapeutics, LLC
SAN JOSE, Calif., Aug. 04, 2023 (GLOBE NEWSWIRE) -- Rani Therapeutics Holdings, Inc. (“Rani Therapeutics” or “Rani”) (Nasdaq: RANI), a clinical-stage biotherapeutics company focused on the oral...
Orthopedic Fracture Repairing Implants for Osteoporosis Market anticipated to reach US$ 4.8 billion by 2031: TMR study
July 31, 2023 11:00 ET
|
Transparency Market Research
Wilmington, Delaware, United States, July 31, 2023 (GLOBE NEWSWIRE) -- The global market for orthopedic fracture repairing implants for osteoporosis was estimated to have acquired a market valuation...